Moleculin Appoints Lead European Principal Investigator for Planned Annamycin Clinical Trial Jul 6, 2017
Reminder: Moleculin Announces Conference Call to Discuss Recent New Discovery for Pancreatic Cancer and Business Update Jun 29, 2017
Moleculin Announces Conference Call to Discuss Recent New Discovery for Pancreatic Cancer and Business Update Jun 27, 2017
Moleculin Announces Intent to Expand Annamycin Planned Clinical Trial to Include Sites in Poland Jun 15, 2017
Moleculin Announces Preparation to File an IND with the FDA for WP1220 for Treatment of Cutaneous T-Cell Lymphoma Jun 13, 2017
